Use Able AI chat for product recommendations

GTF2H5 Polyclonal antibody

GTF2H5 Polyclonal Antibody for ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

IHC, ELISA

C6orf175, GTF2H5, TFB5, TFB5 ortholog, TGF2H5, TTD, TTD A, TTDA

Formulation:  PBS, Azide, Glycerol
Conjugate:  Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for GTF2H5 in ?

Product Information

14539-1-AP targets GTF2H5 in IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag6042

Product name: Recombinant human GTF2H5 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-71 aa of BC060317

Sequence: MVNVLKGVLIECDPAMKQFLLYLDESNALGKKFIIQDIDDTHVFVIAELVNVLQERVGELMDQNAFSLTQK

Predict reactive species
Full Name general transcription factor IIH, polypeptide 5
Calculated Molecular Weight 8 kDa
GenBank Accession NumberBC060317
Gene Symbol GTF2H5
Gene ID (NCBI) 404672
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ6ZYL4
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Publications

What published studies show

The GTF2H5 Polyclonal antibody (Cat# 14539-1-AP) has 1 total citation. It appears in the Journal of Gynecologic Oncology, in a study investigating the NER-related gene GTF2H5 as a survival predictor in high-grade serous ovarian cancer patients. The associated research field is gynecologic oncology, specifically ovarian cancer prognosis and the nucleotide excision repair (NER) pathway. The antibody was applied via IHC on human samples.

SpeciesApplicationTitle
humanIHC

J Gynecol Oncol

The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.

Authors - Javier Gayarre
Loading...
||
New chat

Able™

正在加载,请稍候...